BIOCRYST PHARMACEUTICALS INC — SCHEDULE 13G Filings
2 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by BIOCRYST PHARMACEUTICALS INC (BCRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOCRYST PHARMACEUTICALS INC has filed 2 SCHEDULE 13G documents with the SEC since 2015. To view all SEC filings by BIOCRYST PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001346824-25-000052 | Nov 12, 2025 | — |
| SCHEDULE 13G | — | 0001193805-25-001316 | Sep 19, 2025 | — |